SGEM#262: Omadacycline – Is it non-inferior to linezolid for skin and soft tissue infections?

Studien extrahiert aus dem Podcast von Dr. Ken Milne

• 2019OASIS-1Infection & AntimicrobialsIn 655 adults with acute bacterial skin and skin-structure infections, omadacycline was non-inferior to linezolid for early clinical response at 48–72 hours.
• 2019OPTICInfection & AntimicrobialsIn 774 adults with community-acquired bacterial pneumonia, omadacycline was non-inferior to moxifloxacin for early clinical response.